CELINE CHAUVIN

Céline Chauvin is an experienced research engineer in the U1330 (Childrens’ ONCology rEseaRch uniT).

After a PhD in fundamental research at Université Pierre et Marie Curie, she did a post-doc at Necker Hospital to study the implication of the mTOR pathway in the nutrient response. Then, she joined Franck Bourdeaut's team where she is now implicated in the identification of new therapeutic targets for rhabdoid tumors of the very young children. She is particularly interested in understanding the role of epigenetic regulators in rhabdoid tumors.

She is highly specialised in many domains like cell culture, gene expression and silencing (siRNA, CRISPR-Cas9 technologies), epigenetic (DNA methylation, histone modifications), drug treatment in vitro and in vivo, high-throughput screens, bioinformatic analyses of RNAseq and methylation profiling...